Acuitas Therapeutics Inc.

Canada


Commandez votre montre hebdomadaire Acuitas Therapeutics Inc.
Quantité totale PI 120
Rang # Quantité totale PI 11 125
Note d'activité PI 2,9/5.0    96
Rang # Activité PI 7 067
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

48 4
18 5
40 0
5
 
Dernier brevet 2025 - Galnac lipid compounds for use i...
Premier brevet 2015 - Novel lipids and lipid nanoparti...
Dernière marque 2024 - A
Première marque 2022 - ACUITAS THERAPEUTICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Lipid nanoparticle mrna vaccines. The invention relates to mRNA comprising lipid nanoparticles a...
Invention Galnac lipid compounds for use in lipid nanoparticles. Compounds having the structure of Formula ...
Invention Method of using lipid nanoparticles for intramuscular delivery. Compounds are provided having the...
Invention Cationic lipid compounds for use in lipid nanoparticles. Compounds are provided having the Struct...
Invention Materials and methods for encapsulating therapeutics in lipid nanoparticles. e.g.e.g., mRNA). The...
Invention Cationic lipid compounds for use in lipid nanoparticles. The present disclosure provides cationic...
2024 Invention Kinase inhibitors and particles comprising myc modulators. The present disclosure relates to comb...
Invention Methods of delivering therapeutics using lipid nanoparticles. Disclosed herein are methods for de...
Invention Cationic lipid compounds for use in lipid nanoparticles. Compounds are provided having the follow...
Invention Cationic lipid compounds for use in lipid nanoparticles. Compounds are provided having the follo...
Invention Pegylated lipids. Compounds are provided having the following Formula (I): Compounds are provi...
Invention Pegylated lipids. Compounds are provided having the following Formula (I): (I) or a pharmaceutica...
P/S Lipids used in the manufacture of cosmetics, beverages, food products and food supplements, lipid...
Invention Lipids for lipid nanoparticle delivery of active agents. Compounds are provided having the follo...
P/S Lipids for scientific purposes, research and development purposes, and research laboratory use; l...
Invention Lipids for use in lipid nanoparticle formulations. Compounds are provided having the following s...
Invention Mixed amide ester containing lipids for use in lipid nanoparticles. Compounds are provided havin...
Invention Amide containing lipids. Compounds are provided having the following Formula (I): Compounds ar...
Invention Lipids for use in lipid nanoparticles. Compounds are provided having the following Formula (I): ...
Invention Amide containing lipids. Compounds are provided having the following Formula (I): (I) or a pharma...
Invention Lipids for use in lipid nanoparticles. Compounds are provided having the following Formula (I) or...
Invention Mixed amide ester containing lipids for use in lipid nanoparticles. Compounds are provided having...
Invention Lipids for use in lipid nanoparticle formulations. Compounds are provided having the following S...
Invention Lipids for use in lipid nanoparticle formulations. Compounds are provided having the following St...
Invention Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids. Compounds are pr...
Invention Cationic lipids for use in lipid nanoparticles. Compounds are provided having the following struc...
P/S Lipids for scientific purposes, research and development purposes, and research laboratory use in...
Invention Mrna therapy with reduced immune reactogenicity. The present disclosure provides compositions an...
2023 Invention Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids. Compoun...
Invention Formulations for modulating myc expression. The present disclosure relates to compositions and me...
Invention Lipid nanoparticle formulations. Improved formulations of lipid nanoparticles are provided. Use ...
P/S Lipids, lipid nanoparticles, lipid formulations, and nucleic acids, including messenger RNA, for ...
2022 Invention Fluorinated cationic lipids for use in lipid nanoparticles. Compounds are provided having the fo...
Invention Lipids for use in lipid nanoparticle formulations. Compounds are provided having the following st...
Invention Fluorinated cationic lipids for use in lipid nanoparticles. Compounds are provided having the fol...
P/S Lipids, namely, lipid derivatives for use in the manufacture of pharmaceuticals, vaccines, and dr...
Invention Lipids for lipid nanoparticle delivery of active agents. Compounds are provided having the follow...
2021 Invention Lipids and lipid nanoparticle formulations for delivery of nucleic acids. Compounds are provided...
Invention Nucleoside-modified rna for inducing an adaptive immune response. The present invention relates ...
Invention Lipids and lipid nanoparticle formulations for delivery of nucleic acids. Compounds are provided ...
2020 Invention Improved lipid nanoparticles for delivery of nucleic acids. Lipid nanoparticles having improved ...
2019 Invention Systems and methods for manufacturing lipid nanoparticles and liposomes. Systems including specif...
2018 Invention Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids. Compounds are ...